Search results
The murky, unregulated world of anti-ageing stem cell therapy
Daily Telegraph· 6 days agoFor while there are very few evidence-based stem cell therapies which are officially approved by...
Letters: Fluctuating costs of prescription drugs demand change
Chicago Tribune· 1 day agoUnjust and rapid prescription drug costs continue to put significant financial strain on Illinois...
Letter: Austin patients need easy access to eye doctor
Post-Bulletin· 3 days agoYesterday during my visit to the most wonderful doctor I have ever known and/or worked with as an R.N., I was told that she will no longer be allowed to service those of us in Austin with the ...
Nanoscope Therapeutics Enhances Mutation-Independent Retinal Gene Therapy Programs with Appointment...
Morningstar· 5 days agoDALLAS, April 25, 2024 /PRNewswire/ -- Nanoscope Therapeutics, Inc., a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, announced today the appointment of Allen C. Ho, MD, FACS, FASRS, as Chief Medical
Top 20 biopharma kick off 9.6% market cap surge in Q1 2024 amid Medicare price talks
Pharmaceutical Technology via Yahoo Finance· 4 days agoNonetheless, Vabysmo, approved for wet macular degeneration in 2022, reported a tripling of drug...
Dr. Roach: Eye drops safe to use with AMD medication
Detroit News· 5 days agoDear Dr. Roach: I am a healthy 67-year-old female being treated with Eylea for wet age-related macular degeneration (AMD). Is it safe to use over-the-counter ...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 1 day agoCognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, today announced that the company ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 6 days agoStargardt Disease Market to Grow Rapidly at a CAGR of 32% by 2034 | DelveInsight PR Newswire LAS VEGAS, April 24, 2024 The expected launch of potential therapies may increase the Stargardt disease market size in the coming years, assisted by an
Newswise Expert | Carl Awh, American Society of Retina Specialists
Newswise· 5 days agoCarl Awh, MD (pronounced "Oh") is the President of the Foundation of the American Society of Retina Specialists (ASRS) and Immediate Past President of ASRS. Dr. Awh is an internationally recognized ...
Cognition Therapeutics hits enrollment goal in DLB study By Investing.com
Investing.com· 19 hours agoCognition Therapeutics, Inc. (NASDAQ: CGTX), a biopharmaceutical company focused on...